Supplementary data: Newfoundland and Labrador

This page provides data visualizations related to the priorities for Canada’s cancer system.

Download the data tables and technical appendix for all indicators.

Priority 1 Action 1: Help people to stop smoking or not start in the first place and live healthier lives

Topic: Keeping people smoke-free
Title of image: Percentage of individuals in NL (aged ≥ 12) classified as daily or occasional smokers
Caveats/limitations:

  • This indicator was reported using the Canadian Community Health Survey (CCHS).
  • Individuals who did not respond to the required CCHS questions regarding smoking status were not included in the analysis.
  • The COVID-19 pandemic had major impacts on the data collection operations and response rates for this survey.

NL at 19% in 2020, and 13.4% in 2021. Canada at 14.7% in 2020, and 11.8% in 2021.

Data source: Canadian Community Health Survey

Topic: Keeping people smoke-free
Title of image: Percentage of males in NL (aged ≥ 18) classified as daily or occasional smokers, by household income quintile and sex
Caveats/limitations:

  • The COVID-19 pandemic had major impacts on the data collection operations and response rates for this survey.
  • Interpret with caution owing to large variability in the 2021 estimates.

Quintile 1 was 38.6% in 2019 and 25.4% in 2021. Quintile 2 was 19.2% in 2019 and 16.9% in 2021. Quintile 3 was 24.1% in 2019 and 18.3% in 2021. Quintile 4 was 25.2% in 2019 and 9.3% in 2021. Quintile 5 was 16% in 2019 and 9.9% in 2021.

Data source: Canadian Community Health Survey

Topic: Keeping people smoke-free
Title of image: Percentage of females in NL (aged ≥ 18) classified as daily or occasional smokers, by household income quintile
Caveats/limitations:

  • The COVID-19 pandemic had major impacts on the data collection operations and response rates for this survey.
  • Interpret with caution owing to large variability in the 2021 estimates.

Quintile 1 was 31.8% in 2019 and 20.9% in 2021. Quintile 2 was 23.4% in 2019 and 18.2% in 2021. Quintile 3 was 11.4% in 2019 and 12.1% in 2021. Quintile 4 was 16.7% in 2019 and 9.2% in 2021. Quintile 5 was 5.5% in 2019 and 6.4% in 2021.

Data source: Canadian Community Health Survey

Topic: Keeping people smoke-free
Title of image: Percentage of males in NL (aged ≥ 18) classified as daily or occasional smokers, by highest level of education
Caveats/limitations:

  • The COVID-19 pandemic had major impacts on the data collection operations and response rates for this survey.
  • Interpret with caution owing to large variability in the 2021 estimates.

Less than secondary school graduation: 30.8 % in 2019, and 25% in 2021. Secondary school graduation and no post-secondary education: 24.9%, and 20.6%. Post secondary education: 21.2% in 2019, and 10.9%.

Data source: Canadian Community Health Survey

Topic: Keeping people smoke-free
Title of image: Percentage of males in NL (aged ≥ 18) classified as daily or occasional smokers, by highest level of education
Caveats/limitations:

  • The COVID-19 pandemic had major impacts on the data collection operations and response rates for this survey.
  • Interpret with caution owing to large variability in the 2021 estimates.

Less than secondary school graduation: 20.1 % in 2019, and 17% in 2021. Secondary school graduation and no post-secondary education: 25.7%, and 17.9%. Post secondary education: 14.5% in 2019, and 10.9%.

Data source: Canadian Community Health Survey

Topic: Maintaining healthy body weight
Title of image: Percentage of individuals in NL (aged ≥ 18) classified as overweight or obese
Caveats/limitations:

  • This indicator was reported using the Canadian Community Health Survey (CCHS). Overall obesity and overweight percentages are reported using 2019 data. Percentages by income quintile and/or sex are reported using 2017-2018 data.
  • Individuals who did not respond to the required CCHS questions to derive the BMI classifications were not included in the analysis.
  • The COVID-19 pandemic had major impacts on the data collection operations and response rates for this survey.

NL at 77.6% in 2019, and 77.9% in 2021. Canada at 65.9% in 2019, and 64.7% in 2021.

Data source: Canadian Community Health Survey

Topic: Maintaining healthy body weight
Title of image: Percentage of individuals in NL (aged ≥ 18) classified as overweight or obese, by sex
Caveats/limitations: The COVID-19 pandemic had major impacts on the data collection operations and response rates for this survey.

Males at 80.5% in 2017-2018, and 81.1% in 2021. Females at 74.7% in 2017-2018, and at 74.9% in 2021.
Data source: Canadian Community Health Survey

Topic: Maintaining healthy body weight
Title of image: Percentage of males in NL (aged ≥ 18) classified as overweight or obese, by income quintile
Caveats/limitations:

  • The COVID-19 pandemic had major impacts on the data collection operations and response rates for this survey.
  • Interpret with caution owing to large variability in the 2021 estimates.

Quintile 1: 68.3% in 2017-2018 and 79.1% in 2021. Quintile 2: 78% in 2017-2018, and 77.9% in 2021. Quintile 3: 82.7% in 2017-2018, and 84% in 2021. Quintile 4: 83.2% in 2017-2018, and 84.6% in 2021. Quintile 5: 86% in 2017-2018 and 79.5% in 2021.

Data source: Canadian Community Health Survey

Topic: Maintaining healthy body weight
Title of image: Percentage of females in NL (aged ≥ 18) classified as overweight or obese, by income quintile
Caveats/limitations:

  • The COVID-19 pandemic had major impacts on the data collection operations and response rates for this survey.
  • Interpret with caution owing to large variability in the 2021 estimates.

Quintile 1: 78.6% in 2017-2018, and 70% in 2021. Quintile 2: 72.4% in 2017-2018, and 73.9% in 2021. Quintile 3: 73.5% in 2017-2018, and 76.8% in 2021. Quintile 4: 76.8% in 2017-2018, and 81.6% in 2021. Quintile 5: 72.5% in 2017-2018, and 72.7% 2021.

Data source: Canadian Community Health Survey

Priority 1 Action 2: Adopt proven practices known to reduce the risk of cancer

Topic: Increasing HPV vaccination
Title of image: Percentage of Grade 6 students in NL who received a final dose of HPV vaccination in the 2018-2019 school year

Overall is 91.6%
Data source: Provincial cancer agencies and programs


Topic: Increasing genetic testing
Title of image: Percentage of patients in NL under 40 years of age diagnosed with colorectal cancer in 2017-2019 who received genetic testing within one year of diagnosis
Caveats/limitations: 2017-2019 years were aggregated as number of colon cases per year were too small to report.
Overall: 58.3%
Data source: Provincial cancer agencies and programs

Priority 2 Action 1: Prioritize rapid access to appropriate diagnosis for those suspected of having cancer

Topic: Reducing wait for diagnosis
Title of image: Median and 90th percentile from time (days) from positive FIT test to diagnosis of colorectal cancer in 2021
Caveats/limitations: 19 days was the average time to positive FIT test to diagnosis of colorectal cancer in 2021

Median is 6 days. 90th percentile is 30 days.

Data source: Provincial cancer agencies and programs

Topic: Diagnosing cancer earlier
Title of image: Proportion of stage 4 diagnosis in NL in 2019
28.6% for lung; 19.3% for colorectal; 4.7% for bladder; 12.8% for melanoma (Stage 3 to 4 combined)
Data source: Provincial cancer agencies and programs

Priority 2 Action 2: Strengthen existing screening efforts and implement lung cancer screening programs across the country

Topic: Increasing participation in colorectal cancer screening
Title of image: Percentage of individuals in NL who had a successful FIT result in 2 years (2018-2019) or a colonoscopy in 5 years (2015-2019)
Overall (Age 50 to 74): 48.8%, Age 50 to 54: 39.1%, Age 55 to 59: 41.1%, Age 60 to 64: 54.7%, Age 65 to 69: 54.4%, Age 70 to 74: 59.5%

Data source: Provincial cancer agencies and programs

Priority 3 Action 1: Set best practices and standards for care delivery and promote their adoption

Topic: Implementing multidisciplinary care
Title of image: Percentage of patients in NL diagnosed with stages 1 to 3 rectal cancer that were discussed at least one time at a Gastrointestinal (GI) tumour board committee
Caveats/limitations:

  • A patient may have been discussed multiple times at a tumour board over the specified time period. This indicator does not capture the frequency of discussions but rather whether a patient was discussed at least one time.
  • For the gastrointestinal tumour board, there is not currently a benchmark for this indicator or criteria for those cases that must be discussed. In general, cases where there are ambiguities about staging, difference of opinion regarding management or uncertainties about the best line of management are brought forth by the attending or triaging physician voluntarily.
  • The COVID-19 pandemic may have affected service provision.

50% in 2019, and 34.1% in 2020.

Data source: Provincial cancer agencies and programs

Topic: Implementing multidisciplinary care
Title of image: Number of pediatric patients in NL discussed at tumour board committee and pediatric patients diagnosed in the same year
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

Discussed at pediatric tumour board committee: 12 cases in 2019, and 11 cases in 2020. Diagnosed with cancer: 14 cases in 2019, and 12 cases in 2020.

Data source: Provincial cancer agencies and programs

Priority 3 Action 2: Eliminate low-benefit practices and adopt high-value practices

Topic: Optimizing care at end of life
Title of image: Percentage of patients diagnosed with invasive cancer and died who received chemotherapy in the last two weeks of life
Caveats/limitations: There is currently no way to determine the cause of death, and there was therefore no way to exclude deaths unrelated to cancer from the denominator.

4.1% in 2018, and 4.5% in 2019.

Data source: Provincial cancer agencies and programs

Topic: Optimizing care at end of life
Title of image: Percentage of patients diagnosed with invasive cancer and died who received chemotherapy in the last two weeks of life

Males: 4.5% in 2018, and 4.4% in 2019. Females: 3.8% in 2018, and 4.6% in 2019.

Data source: Provincial cancer agencies and programs

Topic: Optimizing screening and appropriate follow-up
Title of image: Percentage of people with a cervix who had a Pap smear in 2019, by age group

Under 21: 0.9%. 21 to 24 years: 6.6%. 25 to 69 years: 88.7%. Over 69 years: 3.8%

Data source: Provincial cancer agencies and programs

Priority 3 Action 3: Design and implement new models of care

Topic: Expanding models of care
Title of image: Percentage of new patients with cancer who were current smokers and received a referral to the smoking cessation program
Caveats/limitations:

  • The Smoking Cessation Program runs one morning per week and provides patients with a combination of behavioural therapy and prescription and non-prescription medications. In the past, this was an in-person program, which was only offered in the province’s cancer clinics. Since the COVID-19 pandemic, the program has become telephone-based only and has seen an increase in compliance.
  • The COVID-19 pandemic may have affected service provision.

Overall: 37.8% in 2020, and 41.8% in 2021. Males: 37% in 2020, and 45.7% in 2021. Females: 38.6% in 2020, and 38.1% in 2021.

Data source: Provincial cancer agencies and programs

Priority 4 Action 1: Provide better services and care adapted to the specific needs of underserved groups

Topic: Increasing access to culturally safe care
Title of image: Percentage of patients who reported that they were treated with respect, compassion and treatment was explained in an understandable way
Caveats/limitations:

  • The COVID-19 pandemic may have affected service provision.
  • Experience of Care Questionnaire was administered to Cancer Care patients January 18 to April 30, 2021. Response rate was 23.4% (N=484) and 89.2% (n=430) answered the questionnaire as the patient while 10.8% (n=54) responded as the patient’s family member.
  • This Questionnaire did not collect the ethnicity of its respondents.
  • The plan is to re-administer this Questionnaire in 2025.

Treated with respect: 95.9%. Treated with compassion: 95%. Treatment explained in an understandable way: 91.4%.

Data source:  Provincial cancer agencies and programs

Priority 4 Action 2: Ensure rural and remote communities have the resources required to better serve their people

Topic: Increasing access to virtual care
Title of image: Percentage of patients with cancer from rural/remote communities using virtual health appointment
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

Patient level: 67.9% in 2019-2020, and 86% in 2020-2021. Appointment level: 37% in 2019-2020, and 60.7% in 2020-2021.Data source: Provincial cancer agencies and programs

Topic: Increasing access to virtual care
Title of image: Percentage of patients with cancer from rural/remote communities using virtual health appointment
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

Eastern: 50.6% in 2019-2020, and 81.9% in 2020-2021. Central 73% in 2019-2020, and 90.9% in 2020-2021. Western: 78.5% in 2019-2020, and 91.1% in 2020-2021. Labrador-Grenfell: 82.8% in 2019-2020, and 93.8% in 2020-2021.

Data source: Provincial cancer agencies and programs

Topic: Increasing access to virtual care
Title of image: Percentage of cancer appointments from rural/remote communities using virtual health appointment
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

Eastern: 31.1% in 2019-2020, and 60.7% in 2020-2021. Central: 36.4% in 2019-2020, and 56.3% in 2020-2021. Western: 46.3% in 2019-2020, and 61.4% in 2020-2021. Labrador-Grenfell: 56.3% in 2019-2020, and 72.9% in 2020-2021.

Data source: Provincial cancer agencies and programs

Priority 4 Action 3: Ensure care can be delivered between provinces, territories and federal jurisdictions when needed

Topic: Improving access to timely care for people who need to travel between jurisdictions
Title of image: Average wait time (in days) for patients with cancer who required Allogeneic Stem Cell Transplant (ASCT) treatment outside of their home jurisdiction
Caveats/limitations:

  • All patients from NL must leave the province for Allogeneic Stem Cell Transplantation.
  • Chemotherapy is required to prepare for allogeneic stem cell transplantation. As such, patients must spend about one week receiving chemotherapy before transplantation, making the minimum possible wait time the time for chemotherapy + travel.
  • The COVID-19 pandemic may have affected service provision.

Mean: 177 days in 2019, and 194 days in 2020. Median: 167 days in 2019, and 123 days in 2020.

Data source: Provincial cancer agencies and programs

Priority 5 Action 1: Integrate the full spectrum of information and support services to ensure people are fully supported throughout the cancer experience

Topic: Improving availability of information and support
Title of image: Percentage of cancer patients who reported that they were given enough information about their cancer, its treatments, and the outcome of their cancer
Caveats/limitations:

  • Experience of Care Questionnaire was administered to Cancer Care patients January 18 to April 30, 2021. Response rate was 23.4% (N=484) and 89.2% (n=430) answered the questionnaire as the patient while 10.8% (n=54) responded as the patient’s family member.
  • The plan is to re-administer this Questionnaire in 2025

Instructions to care for yourself: 89%. Contact information for questions: 93.5%. Access to spiritual/religious support: 41.5%. Access emotional or mental health support 59%.

Data source: Provincial cancer agencies and programs

Topic: Improving access to shared medical records
Title of image: Percentage of family physicians in NL who have logged into HEALTHeNL viewer at least 50 times (among family physicians who have access to HEALTHeNL)
Caveats/limitations:

  • Information on patients with cancer is available but it cannot be separated from other patients without cancer at this time. This is a proxy indicator and does not measure access to electronic cancer care information directly. Rather, it measures access to general EMRs, where cancer information is a subset.
  • The COVID-19 pandemic may have affected service provision.

84.9% in 2019. 83.8% in 2020.Data source: Provincial cancer agencies and programs

Topic: Improving access to shared medical records
Title of image: Percentage of family physicians in NL who have logged into HEALTHeNL viewer at least 50 times (among family physicians that have access to HEALTHeNL), by regional health authority
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

Eastern: 86% in 2019, and 83.5% in 2020. Central: 86.8% in 2019, and 86.2% in 2020. Western: 88.7% in 2019, and 86.3% in 2020. Labrador-Grenfell: 83.6% in 2019, and 88.6% in 2020.Data source: Provincial cancer agencies and programs

Priority 5 Action 2: Address the limited and unequal access to palliative and end-of-life care across Canada

Topic: Improving access to quality end-of-life care
Title of image: Cumulative length of stay for cancer patients (overall) who were in or admitted to an acute care hospital 30 days prior to death across NL

2015: Median is 14 days, and 90th percentile is 43 days. 2017. Median is 13 days, and 90th percentile is 43 days. 2019: Median is 11 days, and 90th percentile is 38 days.

Data source: Canadian Institute for Health Information (CIHI), Discharge Abstract Database (DAD)

Topic: Improving access to quality end-of-life care
Title of image: Cumulative length of stay for cancer patients (rural/remote) who were in or admitted to an acute care hospital 30 days prior to death across NL

2015: Median is 14 days, and 90th percentile is 50 days. 2017. Median is 16 days, and 90th percentile is 47 days. 2019: Median is 15 days, and 90th percentile is 45 days.

Data source: Canadian Institute for Health Information (CIHI), Discharge Abstract Database (DAD)

Topic: Improving access to quality end-of-life care
Title of image: Cumulative length of stay for cancer patients (urban) who were in or admitted to an acute care hospital 30 days prior to death across NL

2015: Median is 14 days, and 90th percentile is 48 days. 2017. Median is 14 days, and 90th percentile is 40 days. 2019: Median is 12 days, and 90th percentile is 40 days.

Data source: Canadian Institute for Health Information (CIHI), Discharge Abstract Database (DAD)

Download the data tables and technical appendix for all indicators.